DIALAB
Private Company
Total funding raised: $12.5M
Overview
DIALAB is a well-established, privately-held Austrian diagnostics company with a global footprint, specializing in the manufacturing and distribution of in-vitro diagnostic (IVD) reagents and laboratory instruments. The company has successfully navigated the evolving regulatory landscape, achieving IVDR certification, and serves a broad international market through direct and OEM partnerships. With a focus on supporting clinical laboratories, DIALAB's business model is built on a portfolio of diagnostic tests and compatible instruments, positioning it as an integrated solutions provider in the competitive IVD sector.
Technology Platform
Manufacturer of integrated in-vitro diagnostic (IVD) reagents and clinical laboratory instruments, with IVDR-certified manufacturing and OEM partnership capabilities.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
DIALAB competes in the global in-vitro diagnostics market, which is dominated by giants like Roche, Abbott, Siemens Healthineers, and Danaher. As a mid-sized player, it competes on factors such as product quality, customer service, cost-effectiveness, and flexibility, often targeting specific geographic regions or laboratory segments. It also faces competition from other specialized reagent and instrument manufacturers.